Stories > AnaMar Receives Orphan Drug Designation for AM1476

AnaMar Receives Orphan Drug Designation for AM1476

Advancements in Cancer Treatment and Mar...

Amgen's Obesity Prospects in Focus

Autolus Thrives with $350M Offering and ...

4D Molecular Therapeutics Raises $300 Mi...

89bio to Present pegozafermin for NASH a...

ACTICOR BIOTECH: Financial Report Postpo...